chr5-34020600-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181435.6(C1QTNF3):āc.943C>Gā(p.Leu315Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000285 in 1,614,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000053 ( 0 hom., cov: 33)
Exomes š: 0.000026 ( 0 hom. )
Consequence
C1QTNF3
NM_181435.6 missense
NM_181435.6 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 6.78
Genes affected
C1QTNF3 (HGNC:14326): (C1q and TNF related 3) Enables identical protein binding activity. Involved in several processes, including cellular triglyceride homeostasis; negative regulation of NIK/NF-kappaB signaling; and regulation of cytokine production. Acts upstream of or within negative regulation of gluconeogenesis. Located in extracellular exosome and membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18677211).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QTNF3 | NM_181435.6 | c.943C>G | p.Leu315Val | missense_variant | 6/6 | ENST00000382065.8 | |
C1QTNF3-AMACR | NR_037951.1 | n.751C>G | non_coding_transcript_exon_variant | 6/9 | |||
C1QTNF3 | NM_030945.4 | c.724C>G | p.Leu242Val | missense_variant | 6/6 | ||
C1QTNF3 | NR_146599.1 | n.1534C>G | non_coding_transcript_exon_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QTNF3 | ENST00000382065.8 | c.943C>G | p.Leu315Val | missense_variant | 6/6 | 1 | NM_181435.6 | P4 | |
C1QTNF3 | ENST00000231338.7 | c.724C>G | p.Leu242Val | missense_variant | 6/6 | 1 | A1 | ||
C1QTNF3 | ENST00000513471.5 | n.498C>G | non_coding_transcript_exon_variant | 3/3 | 1 | ||||
C1QTNF3 | ENST00000508398.1 | n.653C>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152220Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251122Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135718
GnomAD3 exomes
AF:
AC:
37
AN:
251122
Hom.:
AF XY:
AC XY:
16
AN XY:
135718
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461854Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727232
GnomAD4 exome
AF:
AC:
38
AN:
1461854
Hom.:
Cov.:
30
AF XY:
AC XY:
18
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74488
GnomAD4 genome
AF:
AC:
8
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
14
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.943C>G (p.L315V) alteration is located in exon 6 (coding exon 6) of the C1QTNF3 gene. This alteration results from a C to G substitution at nucleotide position 943, causing the leucine (L) at amino acid position 315 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Benign
T;D
Sift4G
Benign
T;T
Polyphen
0.85
.;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at